Authors:
FUGLSANG G
VIKREJORGENSEN J
AGERTOFT L
PEDERSEN S
Citation: G. Fuglsang et al., EFFECT OF SALMETEROL TREATMENT ON NITRIC-OXIDE LEVEL IN EXHALED AIR AND DOSE-RESPONSE TO TERBUTALINE IN CHILDREN WITH MILD ASTHMA, Pediatric pulmonology, 25(5), 1998, pp. 314-321
Citation: L. Agertoft et S. Pedersen, BONE-MINERAL DENSITY IN CHILDREN WITH ASTHMA RECEIVING LONG-TERM TREATMENT WITH INHALED BUDESONIDE, American journal of respiratory and critical care medicine, 157(1), 1998, pp. 178-183
Citation: L. Agertoft et al., POSTERIOR SUBCAPSULAR CATARACTS, BRUISES AND HOARSENESS IN CHILDREN WITH ASTHMA RECEIVING LONG-TERM TREATMENT WITH INHALED BUDESONIDE, The European respiratory journal, 12(1), 1998, pp. 130-135
Citation: L. Agertoft et S. Pedersen, IMPORTANCE OF TRAINING FOR CORRECT TURBUHALER USE IN PRESCHOOL-CHILDREN, Acta paediatrica, 87(8), 1998, pp. 842-847
Citation: L. Agertoft et S. Pedersen, CALCULATION OF THE MINIMAL EFFECTIVE DOSE FOR FLUTICASONE PROPIONATE AND BUDESONIDE IN CHILDREN - REPLY, Journal of allergy and clinical immunology, 101(2), 1998, pp. 289-290
Citation: L. Agertoft et S. Pedersen, SHORT-TERM KNEMOMETRY AND URINE CORTISOL EXCRETION IN CHILDREN TREATED WITH FLUTICASONE PROPIONATE AND BUDESONIDE - A DOSE-RESPONSE STUDY, The European respiratory journal, 10(7), 1997, pp. 1507-1512
Citation: L. Agertoft et S. Pedersen, A RANDOMIZED, DOUBLE-BLIND DOSE REDUCTION STUDY TO COMPARE THE MINIMAL EFFECTIVE DOSE OF BUDESONIDE TURBUHALER AND FLUTICASONE PROPIONATE DISKHALER, Journal of allergy and clinical immunology, 99(6), 1997, pp. 773-780
Authors:
FUGLSANG G
VIKREJORGENSEN J
AGERTOFT L
PEDERSEN S
Citation: G. Fuglsang et al., INFLUENCE OF SALMETEROL TREATMENT UPON NITRIC-OXIDE LEVEL IN EXHALED AIR AND BRONCHODILATOR RESPONSE TO TERBUTALINE IN CHILDREN WITH MILD ASTHMA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1318-1318
Authors:
FUGLSANG G
AGERTOFT L
VIKREJORGENSEN J
PEDERSEN S
Citation: G. Fuglsang et al., INFLUENCE OF BUDESONIDE ON THE RESPONSE TO INHALED TERBUTALINE IN CHILDREN WITH MILD ASTHMA, Pediatric allergy and immunology, 6(2), 1995, pp. 103-108
Citation: L. Agertoft et S. Pedersen, EFFECTS OF LONG-TERM TREATMENT WITH AN INHALED CORTICOSTEROID ON GROWTH AND PULMONARY-FUNCTION IN ASTHMATIC-CHILDREN, Respiratory medicine, 88(5), 1994, pp. 373-381
Authors:
VERDER H
ROBERTSON B
GREISEN G
EBBESEN F
ALBERTSEN P
LUNDSTROM K
JACOBSEN T
AGERTOFT L
HOBOLTH N
DJERNES B
GRYTTER C
HERTEL J
HOLM V
HANSEN US
KAMPER J
JOHANSEN KH
NATHAN E
LANGE A
PEITERSEN B
PEDERSENBJERGAARD L
SKOV L
SVENNINGSEN N
CURSTEDT T
BERTELSEN A
VESTERGAARD A
PETERSEN E
Citation: H. Verder et al., SURFACTANT THERAPY AND NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR NEWBORNS WITH RESPIRATORY-DISTRESS SYNDROME, The New England journal of medicine, 331(16), 1994, pp. 1051-1055
Citation: L. Agertoft et S. Pedersen, INFLUENCE OF SPACER DEVICE ON DRUG-DELIVERY TO YOUNG-CHILDREN WITH ASTHMA, Archives of Disease in Childhood, 71(3), 1994, pp. 217-219
Citation: L. Agertoft et S. Pedersen, IMPORTANCE OF THE INHALATION DEVICE ON THE EFFECT OF BUDESONIDE, Archives of Disease in Childhood, 69(1), 1993, pp. 130-133
Citation: S. Pedersen et L. Agertoft, EFFECT OF LONG-TERM BUDESONIDE TREATMENT ON GROWTH, WEIGHT AND LUNG-FUNCTION IN CHILDREN WITH ASTHMA, The American review of respiratory disease, 147(4), 1993, pp. 265-265